Video & Transcript Research : 'FDA'

Page 4 of 60
TX

Texas 89th Regular

Agriculture & Livestock Aug 19th, 2025

Agriculture & Livestock

Transcript Highlights:
  • Kennedy Jr., and the FDA for authorizing the emergency measures.
  • FDA and EPA to expand treatment options.
  • Legal through FDA, EPA, and then it's something we could consider.
  • What you want to do is to get further approval from the FDA.
  • But it really comes down to the FDA, their given FDA clearance numbers.
Keywords: 997, house, all
AZ

Arizona 2026 Regular Session

03/23/2026 - House Public Safety & Law Enforcement

Public Safety & Law Enforcement

Transcript Highlights:
  • Any other kind of psychedelic that is not approved by the FDA—most of them aren’t approved by the FDA—if
  • One, most of them aren’t approved by the FDA.
  • The FDA is finally to the point where they’re probably going to approve it.
  • The FDA is finally to the point where they’re probably going to approve it.
  • The FDA is finally to the point where they're probably going to approve it.
Summary: The committee first heard SB 1161, which would prevent lapse of a $750,000 FY2026 appropriation to DPS for the Yuma County Family Advocacy Center (Amberly’s Place). Testimony described the center’s 24/7 crisis response, forensic interview and medical services, and satellite offices in nearby communities. The bill was moved and received a do pass recommendation on an 11-0 roll call, with three members absent. The committee then considered SB 1215, a clarifying bill on the list of cancers covered by the occupational disease presumption for firefighters and peace officers, with a retroactivity amendment to June 30, 2021. Firefighters’ representatives said the measure corrects a drafting issue involving adenocarcinoma and would prevent denials of claims; members asked about peace officer coverage, independent medical exams, and workers’ compensation impacts. The amendment was adopted and the bill received a do pass recommendation, with 11 ayes, one present, and two absent. SB 1270, dealing with supplemental employer contributions to defined contribution accounts for corrections employees, drew testimony focused on severe retention problems in corrections and county detention. Supporters said the bill would allow optional incentive payments at service intervals to help keep trained officers on the job; members discussed vesting, recruitment versus retention, and whether the program could be funded without a new appropriation. The committee adopted the amendment and gave the bill a do pass recommendation, with ten ayes, one nay, two present, and one absent. The committee also heard SB 1400, authorizing law enforcement wellness and crisis response programs and setting confidentiality rules. Police association testimony supported the concept but noted concerns about the breadth of the privilege carve-outs, especially if licensed therapists are involved; several members said they would support the bill after an amendment clarifying privilege protections. The bill was reported do pass with ten ayes, one nay, and two present. SB 1538, as a strike-everything amendment, would require workers’ compensation coverage for PTSD treatment for firefighters and peace officers and allow one MDMA treatment course if federal approval and rescheduling occur by January 1, 2029. Supporters described promising clinical trial results and argued it could help severe PTSD cases, while county representatives opposed the mandate and raised cost and approval concerns. The amendment was adopted and the bill received a do pass recommendation, with seven ayes, three nays, and one present. Finally, the committee considered SB 1537, renaming the peace officer training equipment fund as the public safety de-escalation and life safety fund and repealing its advisory commission. Testimony explained the change was meant to reduce confusion between similar funds and reflect the fund’s use for de-escalation and safety equipment; some members noted opposition from the Arizona Police Association and concerns about whether the money might be better used for raises. The bill passed on a 7-4 vote with three absent. The committee then began SB 1580, which would appropriate Peace Officer Training Equipment Fund money for fire incident management support and other public safety equipment, including pepperball equipment, simulators, records management software, and retention/recruitment efforts. Testimony supported the equipment and data-sharing investments, but members also questioned accountability, ongoing costs, and whether the listed uses were the best use of the fund.
MN
Transcript Highlights:
  • There are now two FDA-approved treatments designed to slow dementia progression for those in the early
  • These FDA-approved drugs are covered by Medicare for those who are age 65, also by Medicaid and by the
  • By mandating insurance coverage of new FDA-approved Alzheimer's treatments for Minnesotans on private
  • It was FDA-approved in July of 2023 after a comprehensive evaluation.
  • consider it experimental when it is FDA consider it experimental when it is FDA approved<00:10:38.639
Keywords: 1187, senate, all
KY

Kentucky 2026 Regular Session

House Legislative Session Day 52 (3-24-26)

Kentucky House Floor Meeting

Transcript Highlights:
  • It does not mean the FDA has reviewed it. It does not mean the FDA has approved it.
  • Um, again, as part of the FDA FDA site and paid a fee. It does not FDA site and paid a fee.
  • It does mean the FDA has reviewed it.
  • not mean the FDA has approved it. not mean the FDA has approved it.
  • the FDA looks at is the instructions for use.
Keywords: 958, all
TX

Texas 89th 2nd C.S.

Agriculture & Livestock Aug 19th, 2025

Agriculture & Livestock

Transcript Highlights:
  • Kennedy Jr. and the FDA for authorizing the emergency use of animal drugs through the FDA to help combat
  • Um, we've also worked with USDA, FDA, and EPA to expand treatment options.
  • So, um, But, um, yeah, that would be an FDA question.
  • This What do you all interpret today's announcement from the FDA? To me.
  • Is to get further approval from FDA.
WV
Transcript Highlights:
  • Would it be the FDA? That's correct. It would be the FDA. Okay.
  • The FDA has also lost approximately 20% of its staff, making it even less likely that the FDA will move
  • So would any action from the FDA then make this void?
  • The FDA does what’s considered GRAS, generally recognized as safe, and…” “The FDA does what’s considered
  • The FDA doesn’t take that into account.
Keywords: 994, senate, all
Summary: The committee first approved the minutes and then took up House Bill 4852, a strike-and-insert bill revising West Virginia’s food additive restrictions. Counsel explained that it moved the existing additive list into a new code section, kept the 2028 effective date, added exceptions for dietary supplements, alcoholic liquor, non-intoxicating beer, and small sellers under $5,000 per month, and created civil penalties for knowing violations. Testimony split between industry witnesses, who argued the bill and last year’s law would raise costs, burden interstate commerce, and conflict with federal regulation, and advocates who said the law is already prompting companies to reformulate and that the bill clarifies vague language tied to a federal injunction. Several amendments were offered to tie the law to FDA action or exempt soda, pepperoni rolls, frozen confections, and snack foods; some were adopted and others failed. The committee then adopted the strike-and-insert amendment as amended and reported HB 4852 to the full Senate with a do-pass recommendation. The committee next considered House Bill 5484, which creates felony offenses for interfering with a victim’s access to medical treatment or forensic care related to a sexual offense, or for forcing a victim of a sexual offense who becomes pregnant to have an illegal abortion, along with a conspiracy offense. Counsel said the strike-and-insert added clarifying language and definitions. Members raised concerns that the conspiracy language could be read to include the victim herself, and the bill sponsor said the intent was to target traffickers and abusers who keep victims from medical care and force abortions outside medical facilities. An amendment was adopted clarifying that nothing in the subsection imposes criminal liability on the victim of the sexual offense. The committee then adopted the strike-and-insert amendment, reported HB 5484 to the full Senate with a do-pass recommendation, and adopted a title amendment. The final bill discussed in the excerpt was House Bill 4468, which narrows confidentiality protections for victims in criminal complaints by limiting redaction to names and addresses, while still allowing disclosure to other governmental entities and permitting victims to request redaction of addresses from appellate decisions after July 1, 2026. Counsel said the bill would replace broader existing confidentiality language and remove provisions allowing disclosure upon a showing of justice or by subpoena. Members questioned whether the change would weaken victim privacy protections, noting that identifying information can include much more than names and addresses. The committee then began hearing testimony from a county prosecutor on the bill, but the excerpt ends before any vote or final action on HB 4468.
TX

Texas 89th Regular

Health and Human Services (Part II) May 7th, 2025

Health & Human Services

Transcript Highlights:
  • The CDC... ...on even though they were FDA approved initially.
  • We gave a FOIA request to the FDA for the Pfizer shot information that they had turned into the FDA.
  • We gave a FOIA request to the FDA for the Pfizer shot information that they had turned into the FDA.
  • at the FDA to release this."
  • But FDA has a legitimate process, and it has But FDA has a legitimate process, and it has worked well
Summary: The committee first reopened testimony on House Bill 2216, which would strengthen child welfare requirements by expanding “active efforts” to help families avoid removal and support reunification, while also raising standards related to removals and terminations. Supporters from child welfare and family defense groups said the bill would better protect families and align Texas more closely with ICWA-style principles, but several warned it would require significant new funding, staffing, and community services such as mental health care, housing, child care, and substance use treatment. The committee then left HB 2216 pending. The committee next heard Senate Bill 1782, aimed at boarding and group homes. Senator Miles said the bill closes enforcement gaps left by prior law by requiring retention of background-check records and creating misdemeanor penalties for failing to conduct or keep them, or for knowingly hiring people with serious convictions. Harris County sheriff’s investigators testified in support, describing illegal boarding homes, operators who evade permits and background checks, and exploitation of vulnerable residents; the bill was left pending. The committee also took up Senate Bill 481 on emergency preparedness for nursing facilities and assisted living facilities, adopted a new committee substitute that softened some requirements and removed the fiscal note, and left the bill pending. The committee then heard House Bill 388, which would require the Texas Department of Insurance to create a single standardized coordination-of-benefits form for dual health plans to reduce errors and surprise bills; it was left pending. Senate Bill 1590 would move paternity registry searches for adoptions to an electronic process with a 10-day target, and House Bill 2809 would track child suicide attempts in managing conservatorship and require related reporting and parental notice; both were left pending. The committee also heard Senate Bill 1887, which would prohibit administering mRNA-containing products for immunization for 10 years, with exceptions for cancer and genetic disorders. Supporters argued the bill was needed for safety, informed consent, and medical freedom, while opponents from the medical, research, and public health communities said mRNA vaccines are well-studied, save lives, and that the bill would harm access, research, and Texas’s biotech economy. The bill remained under discussion as testimony concluded.
WY

Wyoming 2026 Regular Session

House Labor, Health & Social Services Committee, February 25, 2026

Labor, Health & Social Services

Transcript Highlights:
  • This is FDA rules, Food and Drug Administration rules, 351 versus 361.
  • rules, F and Drug this is this is um FDA rules, F and Drug Administration<00:07:19.919> rules
  • is not keeping up with further is FDA is not keeping up with the<00:08:17.759> science<00:08:
  • FDA um limitation.<00:08:51.839> Madam<00:08:52.240> Chairman, limitation.
  • Push towards it on the FDA?
Bills: HB0003, HB0117, HB0041
TX
Transcript Highlights:
  • The FDA moved that up to 10 weeks.
  • The FDA has labeled Kratom as a drug of concern and has stated that there are no FDA-approved uses.
  • I was at the FDA for about 12 years, the last six of which I served as the Deputy Director of FDA.
  • Back to the FDA, I'm confused.
  • That's an FDA statement. I'm sorry. I didn't actually. So I have a statement from the FDA.
TX

Texas 89th Regular

Public Education Apr 8th, 2025

Public Education

Transcript Highlights:
  • I think the state and certainly the FDA is way behind on this.
  • I said that, I thought the FDA no longer did a very good job of doing that.
  • Y'all are clear as long as the FDA approves it, right?
  • As long as the FDA, if the FDA says it's okay, does that mean you have no liability?
  • waiting, essentially, for the FDA to tell you. Not at all. Not at all.
TX

Texas 89th Regular

Public Health Apr 21st, 2025

Public Health

Transcript Highlights:
  • States can allow pharmacists to dispense the drug without FDA approval, but FDA approval would be required
  • I mean, I know the FDA decides a lot of that, but does DSA?
  • It is an FDA determination and the medication we're talking about here is... is per the FDA considered
  • So Fauci at the FDA or had the FDA declare it. a veterinary medicine only, and encouraged American people
  • And that requires FDA approval. Right. FDA approval to have Tylenol on the shelf. Yes.
TX

Texas 89th Regular

Senate Session (Part III) Aug 27th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • It is not FDA-approved for human consumption on viruses. Is that accurate? It is FDA approved.
  • In humans, drugs are approved through the FDA.
  • Ivermectin is FDA approved for certain uses, but it is not safe.
  • The FDA and only the FDA, which is currently headed by...
  • States do not have the authority to require the sale of FDA prescription drugs, i.e., FDA legend drugs
CA

California 2025-2026 Regular Session

Senate Health Committee Jun 24th, 2026

Health

Transcript Highlights:
  • The FDA doesn't currently have a standard, but we've also offered the author language that if the FDA
  • And this information is already available on the FDA website.
  • I mean, FDA is in charge of our label.
  • We couldn't... ...minute it is, we have to get it approved by FDA.
  • monitored by the FDA and you meet all the requirements.
Keywords: 987, senate, all
WY

Wyoming 2026 Regular Session

House Judiciary Committee, February 25, 2026

Judiciary

Transcript Highlights:
  • This was direct language from the FDA, so there is concern there.
  • According to the FDA, it is not currently regulated.
  • is not currently regulated by the FDA. is not currently regulated by the FDA.
  • According to the FDA, it is not Uh, yes.
  • <00:59:24.079> cratom The FDA has also documented cratom The FDA has also documented cratom
Bills: SF0071, SF0088, SF0056
TX

Texas 89th 2nd C.S.

Public Health Apr 21st, 2025

Public Health

Transcript Highlights:
  • Currently, states can allow pharmacists to dispense the drug without FDA approval, but FDA approval would
  • That is an FDA determination.
  • It is an FDA determination, and the medication we’re talking about here is, per the FDA, considered a
  • “So Fauci at the FDA, or had the FDA declared it a veterinary medicine only and encouraged American people
  • Representative Frank: And that requires FDA approval, right? So who requires FDA approval?
Bills: HB216
Summary: The Committee on Public Health met with a quorum and heard public testimony on a long agenda, with members repeatedly reminded of a two-minute limit for witnesses. Several bills were voted out favorably, including HB 2588 on cottage food, HB 1639 on cancer incidence and female firefighters, HB 2581 on a reporting form for contracted services for pregnant women, and SB 922 on electronic disclosure of certain sensitive medical information. Those measures generally passed on party-line or near-unanimous votes, while HB 216 on itemized medical statements was left pending after the committee substitute was withdrawn. The committee also left pending HB 5141, HB 4638, HB 2035, HB 4813, HB 2264, HB 4014, and HB 3829 after hearing testimony and questions. The final item introduced in the excerpt was HB 4408 on health care market transparency and corporate consolidation, but the discussion was cut off before testimony or action was completed. A major theme of the hearing was mental health diversion and access to treatment. HB 5141, by Rep. Howard, would allow Travis County to use vacated Austin State Hospital property for a local mental health jail diversion center; law enforcement, the Travis County sheriff, county judge, and urban counties group all testified in support, describing the lack of alternatives for people in crisis and the burden on jails and emergency rooms. Members asked about eligible offenses, bed capacity, and whether the facility would serve only Travis County, and the bill was left pending. HB 2264, by Rep. Schoolcraft, would create a friends-and-family form for loved ones to provide information to providers during emergency mental health treatment; NAMI and hospital groups supported it, while one neutral witness and several members raised concerns about patient control, credibility of information, and liability protections. The bill was also left pending. The committee also heard multiple psychedelic-therapy and drug-policy bills. HB 4813 would speed Texas rescheduling of Schedule I substances if the FDA reclassifies them, with testimony focused on psilocybin and MDMA and their potential use for PTSD and depression; members questioned whether the bill was too broad and how state rescheduling works, and it was left pending. HB 4014 would direct HHSC to study psychedelic therapies, building on prior state research, and witnesses said Texas should prepare regulatory and clinical infrastructure before FDA approval; it too was left pending. HB 2035 would require parents to be informed that they may seek substance-use treatment for a child even if one facility turns them away, prompted by a constituent’s account of a fatal fentanyl overdose after receiving incorrect advice; it was left pending. HB 4638 would extend and expand the Texas Pharmaceutical Initiative board and timeline, with the author saying the program is still in early implementation and needs more time, and it was left pending as well. Other bills addressed public health administration and animal welfare. HB 3829 would require a study of the animal-friendly account and its grant process for spay/neuter funding, with the author arguing that the current application and reimbursement process is too burdensome for shelters and nonprofits; no opposition was heard and the bill was left pending. HB 2581 and HB 1639 were reported favorably, while HB 216 drew discussion about enforcement of itemized medical billing and was held after the committee substitute was withdrawn. Throughout the hearing, members also discussed broader concerns about homelessness, competency restoration waitlists, jail overcrowding, and the need for more treatment options outside the criminal justice system.
TX
Transcript Highlights:
  • What is ivermectin FDA approved for?
  • Do you know what the FDA said? No, that's correct.
  • So is ivermectin an FDA-approved drug? Yes.
  • That is what it is currently FDA approved for. And.
  • It's FDA approved for parasitic... ...infections.
NY

New York 2025-2026 Regular Session

Senate Standing Committee on Agriculture - 01/29/2026

Agriculture

Transcript Highlights:
  • law, food producers may, if they have an ingredient they want to get into food, either submit to the FDA
  • Red Dye No. 3 has been banned for more than a decade in cosmetics, but somehow the FDA has left it for
  • When you can ask the FDA to determine that something's generally recognized as safe, and if you do that
  • If the FDA is reviewing the substance, it has no effect at all.
  • FDA recommend, et cetera. But it must be there is a language.
Keywords: 993, senate, all
Summary: The Agriculture Committee met for its first 2026 meeting and took up a full agenda of bills focused on food safety, agricultural programs, consumer transparency, and farm-related policy. Early measures included S.592 on a youth and agriculture entrepreneurship summer employment program, which was reported to finance without opposition, and S.1239E, the Food Safety and Technical Disclosure Act, which would require disclosure of certain food ingredients to the state and public and also ban three substances outright. Senator Kavanaugh described the bill as closing a loophole in federal food safety law; Senator Borrello opposed it as a state-by-state approach that could raise costs and disrupt the supply chain, while Senator O’Rourke supported it as a science-based measure with available substitutes. The bill was reported back to the board with one no vote and one without recommendation. The committee also advanced S.1783A on liquefied petroleum/propane fee disclosures, with supporters saying it would prevent consumers from being charged for improper or hidden fees and opponents arguing it should not single out state-related charges; the bill moved to the board. S.4041, creating a sanitary retail food store grant program, was reported to finance. S.4162, relating to the Fresh Connect program and local produce purchases, prompted discussion about whether state resources should instead be concentrated on the Double Up Food Bucks program; sponsors said both programs are needed and that Double Up has capacity limits, and the bill was moved to finance. Later, the committee advanced S.6286A, establishing an agricultural tax viability pilot program tied to agrivoltaics; supporters said it would address a need raised in recent hearings and work with farm groups, while Senator Borrello voted no. The final bill, S.7618 on food safety and quality date label requirements, drew debate over whether New York should act without a federal standard and whether the bill could create confusion or unintended costs, especially for dairy and other perishables. Supporters said the bill would reduce food waste and simplify the many existing date labels without forcing new labeling on those who do not already use it; members also discussed refrigeration references in the bill, and the sponsor said the language could be adjusted. The committee then adjourned and announced that future meetings will be held on the third floor in the new location.
TX
Transcript Highlights:
  • FDA.
  • at the FDA to release this for 75 years."
  • Has the FDA, CDC ever published any public guidance on DNA contamination in these shots?
  • approved, like Vioxx, which was ultimately withdrawn despite being FDA approved.
  • It built upon decades of foundation... research to develop the first FDA-approved mRNA vaccines.
DE

Delaware 2025-2026 Regular Session

House Economic Development/Banking/Insurance & Commerce Committee Meeting Jun 23rd, 2026

Economic Development/Banking/Insurance & Commerce

Transcript Highlights:
  • Covered services include, but are not limited to, diagnostic testing, FDA-approved hormonal therapies
  • What the changes do is make it more explicit that HRT treatment must be approved by the FDA to be covered
  • Yes. and has an FDA approval, nor subject to prior authorization or step therapy requirements.
  • What the changes do is to make it more explicit that HRT treatment must be approved by the FDA to be
  • These include widely recognized and FDA approved treatments including hormone replacement therapy, early
Summary: The committee met with roll call attendance and took up two bills. First was Senate Bill 315 with Senate Amendment 1, which would allow the Division of Small Business to add state funding to existing federal small business programs, including the Small Business Innovation Research and Small Business Technology Transfer programs. There was brief public support from one in-person commenter, no virtual comment, and the committee voted to release the bill, though it did not yet have enough signatures for immediate release and was left open for absent members to sign. The second item was Senate Substitute 1 for Senate Bill 319, a women’s health insurance mandate requiring coverage for medically necessary menopause and perimenopause diagnostic and treatment services, including FDA-approved hormone replacement therapy, pelvic floor therapy, and related care. Representative Smith presented the bill as a response to gaps in menopause care and insurance coverage, and Department of Insurance witness Kennedy Cook explained the religious exemption as applying to certain religious employers and blanket health policies. Committee members asked about the scope of that exemption, and some expressed concern about religious carveouts, while others praised the bill as important women’s health legislation. During public comment, one speaker supported the bill but warned that expanding mandatory health benefits can raise insurance costs. The Department of Insurance then testified in support, saying the bill would align Delaware with other states, many insurers already comply, and the department did not expect a meaningful premium impact. The committee voted to release Senate Substitute 1 for Senate Bill 319 from committee.